Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.334 USD | +25.28% |
|
+38.02% | -85.85% |
Business Summary
Number of employees: 35
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Glycomimetic Compounds
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -86.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 06/21/06 |
Rachel King
FOU | Founder | 64 | 04/03/04 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 01/10/01 |
Edwin Rock
CTO | Chief Tech/Sci/R&D Officer | 63 | 06/22/06 |
Chinmaya Rath
PRN | Corporate Officer/Principal | 48 | - |
Bruce Johnson
PRN | Corporate Officer/Principal | 56 | 23/22/23 |
General Counsel | - | 29/19/29 | |
Comptroller/Controller/Auditor | 53 | 01/14/01 | |
Lisa V. DeLuca
LAW | General Counsel | - | 22/21/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 17/16/17 |
Patricia Andrews
BRD | Director/Board Member | 66 | 12/17/12 |
Scott Jackson
BRD | Director/Board Member | 59 | 28/18/28 |
Rachel King
FOU | Founder | 64 | 04/03/04 |
Scott Koenig
BRD | Director/Board Member | 71 | 13/17/13 |
Timothy Pearson
CHM | Chairman | 56 | 31/14/31 |
Mark Goldberg
BRD | Director/Board Member | 69 | 10/14/10 |
Harout Semerjian
CEO | Chief Executive Officer | 52 | 06/21/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,464,412 | 62,461,710 ( 96.89 %) | 0 | 96.89 % |
Company contact information
GlycoMimetics, Inc.
9708 Medical Center Drive
20850, Rockville
+240 243 1201
http://www.glycomimetics.com![address GlycoMimetics, Inc.(GLYC)](https://cdn.zonebourse.com/static/address/14850833.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.85% | 2.15Cr | |
+16.45% | 12TCr | |
+21.96% | 12TCr | |
+25.44% | 2.7TCr | |
-20.05% | 2.04TCr | |
-16.28% | 1.59TCr | |
-15.94% | 1.64TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.49TCr | |
+2.52% | 1.36TCr |
- Stock Market
- Equities
- GLYC Stock
- Company GlycoMimetics, Inc.